Intraovarian thrombin and activated protein C signaling system regulates steroidogenesis during the periovulatory period.
In addition to its role in blood coagulation, thrombin directly stimulates protease-activated receptors (PAR) or interacts with thrombomodulin (THBD) to activate membrane-bound protein C which stimulates PAR1 and PAR4 receptors to promote downstream pleiotropic effects. Our DNA microarray, RT-PCR, and immunostaining analyses demonstrated ovarian expression of THBD, activated protein C (APC) receptor [endothelial protein C receptor (EPCR)], as well as PAR1 and PAR4 receptors in mice. After treatment of gonadotropin-primed immature mice with an ovulatory dose of human chorionic gonadotropin (hCG) (a LH surrogate), major increases in the expression of THBD, EPCR, PAR1, and PAR4 were detected in granulosa and cumulus cells of preovulatory follicles. Immunoassay analyses demonstrated sustained increases in ovarian prothrombin and APC levels after hCG stimulation. We obtained luteinizing granulosa cells from mice treated sequentially with equine CG and hCG. Treatment of these cells with thrombin or agonists for PAR1 or PAR4 decreased basal and forskolin-induced cAMP biosynthesis and suppressed hCG-stimulated progesterone production. In cultured preovulatory follicles, treatment with hirudin (a thrombin antagonist) and SCH79797 (a PAR1 antagonist) augmented hCG-stimulated progesterone biosynthesis, suggesting a suppressive role of endogenous thrombin in steroidogenesis. Furthermore, intrabursal injection with hirudin or SCH79797 led to ipsilateral increases in ovarian progesterone content. Our findings demonstrated increased ovarian expression of key components of the thrombin-APC-PAR1/4 signaling system after LH/hCG stimulation, and this signaling pathway may allow optimal luteinization of preovulatory follicles. In addition to assessing the role of thrombin and associated genes in progesterone production by the periovulatory ovary, these findings provide a model with which to study molecular mechanisms underlying thrombin-APC-PAR1/4 signaling.
Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305-5317, USA.
Yuan
Y
Cheng
Kazuhiro
K
Kawamura
Masashi
M
Deguchi
Seido
S
Takae
Sabine M
SM
Mulders
Aaron J W
AJ
Hsueh
D000818:Animals; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis; D005260:Female; D015870:Gene Expression; D051379:Mice; D006080:Ovarian Follicle / Q000187:drug effects / Q000378:metabolism; D010053:Ovary / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D010060:Ovulation; D011374:Progesterone / Q000096:biosynthesis*; D011486:Protein C / Q000378:metabolism*; D011516:Prothrombin / Q000378:metabolism; D044463:Receptor, PAR-1 / Q000235:genetics / Q000378:metabolism; D044462:Receptors, Proteinase-Activated / Q000235:genetics / Q000378:metabolism; D012102:Reproductive Control Agents / Q000494:pharmacology; D015398:Signal Transduction; D013917:Thrombin / Q000378:metabolism*; D018180:Thrombomodulin / Q000235:genetics / Q000378:metabolism
D006063:Chorionic Gonadotropin; D011486:Protein C; D044463:Receptor, PAR-1; D044462:Receptors, Proteinase-Activated; D012102:Reproductive Control Agents; D018180:Thrombomodulin; C481942:protease-activated receptor 4, mouse; D011374:Progesterone; D011516:Prothrombin; D000242:Cyclic AMP; D013917:Thrombin